The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACHILLION PHARMACEUTICALS | COM | 00448Q201 | 1,511 | 186,500 | SH | SOLE | 186,500 | 0 | 0 | ||
AEGLEA BIOTHERAPEUTICS INC | COM ADDED | 00773J103 | 2,246 | 350,392 | SH | SOLE | 350,392 | 0 | 0 | ||
AERIE PHARMACEUTICALS INC | COM | 00771V108 | 3,467 | 91,869 | SH | SOLE | 91,869 | 0 | 0 | ||
ALDER BIOPHARMACEUTICALS INC | COM | 014339105 | 5,417 | 165,313 | SH | SOLE | 165,313 | 0 | 0 | ||
APPLIED GENETIC TECHNOL CORP | COM | 03820J100 | 2,350 | 240,298 | SH | SOLE | 240,298 | 0 | 0 | ||
AQUINOX PHARMACEUTICALS INC | COM | 03842B101 | 267 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
ARDELYX INC | COM | 039697107 | 2,835 | 219,095 | SH | SOLE | 219,095 | 0 | 0 | ||
ARRAY BIOPHARMA INC | COM | 04269X105 | 468 | 69,300 | SH | SOLE | 69,300 | 0 | 0 | ||
ASCENDIS PHARMA | SPONSORED ADR | 04351P101 | 618 | 30,750 | SH | SOLE | 30,750 | 0 | 0 | ||
ATRICURE INC | COM | 04963C209 | 8,368 | 528,946 | SH | SOLE | 528,946 | 0 | 0 | ||
AVINGER INC | COM | 053734109 | 147 | 30,800 | SH | SOLE | 30,800 | 0 | 0 | ||
BEIGENE LTD | SPONSORED ADR | 07725L102 | 2,777 | 90,142 | SH | SOLE | 90,142 | 0 | 0 | ||
BIOSPECIFICS TECHNOLOGIES | COM | 090931106 | 1,813 | 39,704 | SH | SOLE | 39,704 | 0 | 0 | ||
BIOTELEMETRY INC | COM | 090672106 | 1,486 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | ||
BLUEBIRD BIO INC | COM | 09609G100 | 407 | 6,000 | SH | SOLE | 6,000 | 0 | 0 | ||
CARA THERAPEUTICS INC | COM | 140755109 | 2,230 | 267,046 | SH | SOLE | 267,046 | 0 | 0 | ||
CATALYST BIOSCIENCES INC | COM | 14888D109 | 86 | 70,903 | SH | SOLE | 70,903 | 0 | 0 | ||
CEL SCI CORP | COM PAR $0.01 | 150837508 | 39 | 127,482 | SH | SOLE | 127,482 | 0 | 0 | ||
CELYAD | ADR | 151205200 | 296 | 12,528 | SH | SOLE | 12,528 | 0 | 0 | ||
CHECK CAP LTD | *W EXP 02/28/202 | M2361E120 | 29 | 51,218 | SH | SOLE | 51,218 | 0 | 0 | ||
COGENTIX MEDICAL INC | COM | 19243A104 | 643 | 353,482 | SH | SOLE | 353,482 | 0 | 0 | ||
CONCERT PHARMACEUTICALS INC | COM | 206022105 | 677 | 66,968 | SH | SOLE | 66,968 | 0 | 0 | ||
CYNAPSUS THERAPEUTICS INC | COM PAR NO PAR | 23257Y859 | 1,264 | 31,537 | SH | SOLE | 31,537 | 0 | 0 | ||
CYNAPSUS THERAPEUTICS INC | COM PAR NO PAR | 23257Y859 | 7,992 | 198,664 | SH | SOLE | 198,664 | 0 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 1,668 | 181,737 | SH | SOLE | 181,737 | 0 | 0 | ||
DERMA SCIENCES INC | COM PAR $.01 | 249827502 | 1,652 | 353,718 | SH | SOLE | 353,718 | 0 | 0 | ||
DERMIRA INC | COM | 24983L104 | 3,341 | 98,800 | SH | SOLE | 98,800 | 0 | 0 | ||
DEXTERA SURGICAL INC | COM ADDED | 252366109 | 264 | 140,275 | SH | SOLE | 140,275 | 0 | 0 | ||
DICERNA PHARMACEUTICALS INC | COM | 253031108 | 701 | 119,300 | SH | SOLE | 119,300 | 0 | 0 | ||
EIGER BIOPHARMACEUTICALS INC | COM | 28249U105 | 1,205 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | ||
ENTEROMEDICS INC COM PAR 0.01 | COM PAR 0.01 | 29365M307 | 5 | 33,334 | SH | SOLE | 33,334 | 0 | 0 | ||
ESSA PHARMA INC | COM | 29668H104 | 733 | 195,496 | SH | SOLE | 195,496 | 0 | 0 | ||
EXACTECH INC | COM | 30064E109 | 855 | 31,636 | SH | SOLE | 31,636 | 0 | 0 | ||
FOAMIX PHARMACEUTICALS LTD | SHS | M46135105 | 2,575 | 278,067 | SH | SOLE | 278,067 | 0 | 0 | ||
GALAPAGOS NV | SPON ADR | 36315X101 | 4,272 | 66,068 | SH | SOLE | 66,068 | 0 | 0 | ||
GENVEC INC | COM NEW | 37246C307 | 45 | 95,800 | SH | SOLE | 95,800 | 0 | 0 | ||
IMMUNE DESIGN CORP | COM | 45252L103 | 303 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
IMMUNOMEDICS INC | COM | 452907108 | 1,842 | 566,796 | SH | SOLE | 566,796 | 0 | 0 | ||
INNOCOLL HLDGS PLC | SHS ADDED | G4783X105 | 581 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
INOTEK PHARMACEUTICALS CORP | NOTE 5.750% 8/0 ADDED | 45780VAB8 | 794 | 600,000 | PRN | SOLE | 600,000 | 0 | 0 | ||
INOTEK PHARMACEUTICALS CORP | COM | 45780V102 | 2,249 | 237,235 | SH | SOLE | 237,235 | 0 | 0 | ||
INSULET CORP | COM | 45784P101 | 3,008 | 73,484 | SH | SOLE | 73,484 | 0 | 0 | ||
INSULET CORP | NOTE 2.000% 6/1 | 45784PAD3 | 2,481 | 2,250,000 | PRN | SOLE | 2,250,000 | 0 | 0 | ||
IRONWOOD PHARMACEUTICALS INC | DBCV 2.250% 6/1 | 46333XAD0 | 717 | 600,000 | PRN | SOLE | 600,000 | 0 | 0 | ||
JOHNSON AND JOHNSON | COM | 478160104 | 1,110 | 9,400 | SH | SOLE | 9,400 | 0 | 0 | ||
LOXO ONCOLOGY INC | COM | 548862101 | 3,409 | 130,222 | SH | SOLE | 130,222 | 0 | 0 | ||
MACROGENICS INC | COM | 556099109 | 1,621 | 54,200 | SH | SOLE | 54,200 | 0 | 0 | ||
MASIMO CORPORATION | COM | 574795100 | 595 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
MINERVA NEUROSCIENCES INC | COM | 603380106 | 467 | 33,100 | SH | SOLE | 33,100 | 0 | 0 | ||
NEOS THERAPEUTICS INC | COM | 64052L106 | 256 | 38,873 | SH | SOLE | 38,873 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 3,241 | 64,008 | SH | SOLE | 64,008 | 0 | 0 | ||
NEURODERM LTD | ORD SHS | M74231107 | 267 | 14,421 | SH | SOLE | 14,421 | 0 | 0 | ||
NIVALIS THERAPEUTICS INC | COM | 65481J109 | 122 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
NOVADAQ TECHNOLOGIES INC | COM | 66987G102 | 1,178 | 101,841 | SH | SOLE | 101,841 | 0 | 0 | ||
NXSTAGE MEDICAL INC | COM | 67072V103 | 5,960 | 238,509 | SH | SOLE | 238,509 | 0 | 0 | ||
OPHTHOTECH CORP | COM | 683745103 | 2,150 | 46,600 | SH | SOLE | 46,600 | 0 | 0 | ||
PALATIN TECHNOLOGIES INC | COM PAR $ .01 | 696077403 | 162 | 257,193 | SH | SOLE | 257,193 | 0 | 0 | ||
PIERIS PHARMACEUTICALS INC | COM | 720795103 | 408 | 223,325 | SH | SOLE | 223,325 | 0 | 0 | ||
PROTAGONIST THERAPEUTICS INC | COM ADDED | 74366E102 | 2,616 | 123,804 | SH | SOLE | 123,804 | 0 | 0 | ||
PROTALIX BIOTHERAPEUTICS INC | NOTE 4.500% 9/1 | 74365AAB7 | 1,525 | 2,500,000 | PRN | SOLE | 2,500,000 | 0 | 0 | ||
RADIUS HEALTH INC | COM NEW | 750469207 | 1,993 | 36,854 | SH | SOLE | 36,854 | 0 | 0 | ||
REGULUS THERAPEUTICS INC | COM | 75915K101 | 1,391 | 421,500 | SH | SOLE | 421,500 | 0 | 0 | ||
RIGEL PHARMACEUTICALS INC | COM NEW | 766559603 | 1,248 | 340,000 | SH | SOLE | 340,000 | 0 | 0 | ||
SCYNEXIS INC | COM | 811292101 | 825 | 213,250 | SH | SOLE | 213,250 | 0 | 0 | ||
SPECTRANETICS CORP | COM | 84760C107 | 1,643 | 65,496 | SH | SOLE | 65,496 | 0 | 0 | ||
STEREOTAXIS INC | COM DELETED | 85916J409 | 1,194 | 1,372,862 | SH | SOLE | 1,372,862 | 0 | 0 | ||
SYNERGY PHARMACEUTICALS | COM | 871639308 | 1,513 | 274,563 | SH | SOLE | 274,563 | 0 | 0 | ||
SYNERON MEDICAL LTD | ORD SHS | M87245102 | 615 | 85,947 | SH | SOLE | 85,947 | 0 | 0 | ||
TANDEM DIABETES CARE INC | COM | 875372104 | 5,548 | 724,286 | SH | SOLE | 724,286 | 0 | 0 | ||
TESARO INC | COM | 881569107 | 2,957 | 29,500 | SH | SOLE | 29,500 | 0 | 0 | ||
UNIQURE B.V. | NV SHS | N90064101 | 1,560 | 203,907 | SH | SOLE | 203,907 | 0 | 0 | ||
VITAE PHARMACEUTICALS INC | COM | 92847N103 | 14,978 | 715,988 | SH | SOLE | 715,988 | 0 | 0 | ||
WINDTREE THERAPEUTICS INC | COM ADDED | 97382D105 | 1,231 | 480,833 | SH | SOLE | 480,833 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 4,164 | 514,091 | SH | SOLE | 514,091 | 0 | 0 | ||
ZOGENIX INC | COM | 98978L204 | 909 | 79,538 | SH | SOLE | 79,538 | 0 | 0 |